Clinical studies recruiting near San Marcos

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in
Phase 3 · Pfizer · NCT06758401 LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Phase 2 · GI Alliance - San Marcos · Eli Lilly and Company · NCT07415044 A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)
Phase 3 · Merck Sharp & Dohme LLC · NCT07044297 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · Kaiser Permanente-San Marcos · NRG Oncology · NCT05174169 Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SL
Phase 3 · Kaiser Permanente-San Marcos · National Cancer Institute (NCI) · NCT04269902 Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and S
Phase 3 · Kaiser Permanente-San Marcos · Canadian Cancer Trials Group · NCT06592924 E-Mindfulness Approaches for Living After Breast Cancer
Phase 3 · Kaiser Permanente-San Marcos · NRG Oncology · NCT06748222 A Study of Dotinurad Versus Allopurinol in Tophaceous Gout
Phase 3 · Epic Medical Research - San Marcos · Crystalys Therapeutics · NCT07089888 Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in
Phase 3 · Merck Sharp & Dohme LLC · NCT03486873 A Dose-masked Study of Intravitreal EYE103 in Participants With NVAMD or Macular Edema Following BRVO
Phase 2 · San Marcos, Texas · EyeBiotech Ltd. · NCT07205887 TREAD: Time Restricted Eating Intervention for Alzheimer's Disease
Phase 1 · University of California, San Diego · NCT06548191 Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
NA · Kaiser Permanente-San Marcos · NRG Oncology · NCT05080673 Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Remo
Phase 2/Phase 3 · Kaiser Permanente-San Marcos · National Cancer Institute (NCI) · NCT05987241 Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers
Phase 2 · Kaiser Permanente-San Marcos · SWOG Cancer Research Network · NCT04205968 A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Le
Phase 3 · Kaiser Permanente - San Marcos · Hoffmann-La Roche · NCT06790693 Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had
Phase 2/Phase 3 · Kaiser Permanente-San Marcos · SWOG Cancer Research Network · NCT06616584 S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic
NA · Kaiser Permanente-San Marcos · SWOG Cancer Research Network · NCT03723928 Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-sm
Phase 3 · Daiichi Sankyo · NCT06899126 A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Al
Phase 3 · Merck Sharp & Dohme LLC · NCT06952504 Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung
Phase 3 · Kaiser Permanente-San Marcos · National Cancer Institute (NCI) · NCT04267848 Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Phase 2/Phase 3 · Kaiser Permanente-San Marcos · SWOG Cancer Research Network · NCT03851445 Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance C
Phase 3 · Kaiser Permanente-San Marcos · National Cancer Institute (NCI) · NCT07061977 Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Phase 3 · Kaiser Permanente-San Marcos · NRG Oncology · NCT06580314 Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A L
Phase 2 · Kaiser Permanente-San Marcos · SWOG Cancer Research Network · NCT05642572 A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colo
Phase 3 · Kaiser Permanente San Marcos Medical Offices · Seagen, a wholly owned subsidiary of Pfizer · NCT05253651 A Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Oral Rilzabrutinib Compared With Placebo in Partici
Phase 3 · Sanofi · NCT07086976 A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Phase 3 · Merck Sharp & Dohme LLC · NCT06925737 Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung
Phase 2 · Kaiser Permanente-San Marcos · SWOG Cancer Research Network · NCT06031688 A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer
Phase 3 · Eli Lilly and Company · NCT07174336 Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal
Phase 3 · Kaiser Permanente-San Marcos · NRG Oncology · NCT05879926

Look up another city

Look up another condition